Nimbus Therapeutics Competitors and Similar CompaniesClear all

Nimbus Therapeutics's competitors and similar companies include Codiak Biosciences, Aligos Therapeutics, Biopharma Informatic and Crozet BioPharma.

	Nimbus Therapeutics Nimbus Therapeutics is a biotechnology company which operates an application of computational chemistry to design treatments for substantial and underserved human diseases.	Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.	Aligos Therapeutics Aligos Therapeutics is a company that develops curative therapies for hepatologic diseases and viral infections.	Biopharma Informatic Biopharma Informatic is a clinical research marketing company.	Crozet BioPharma Crozet BioPharma is a biotechnology company developing medical countermeasures for infectious disease and cancer.
Founding Date	Founding Date 2009	Founding Date 2015	Founding Date 2018	Founding Date 2008	Founding Date 2017
Type	Type Private	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare Technology biotech clinical research oncology pharma	Tags Healthcare biotech therapy	Tags Healthcare biotech drug development	Tags Healthcare biotech clinical research oncology pharma	Tags Healthcare biotech clinical research oncology pharma
Locations	Locations Cambridge, US HQ	Locations Cambridge, US HQ	Locations South San Francisco, US HQ Leuven, BE	Locations Houston, US HQ	Locations Devens, US HQ
Employees	Employees 1091% increase	Employees 992% decrease	Employees 706% increase	Employees 671% decrease	Employees 9
Valuation ($)	Valuation ($) N/A	Valuation ($) 2.8 m	Valuation ($) 28.8 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $22.9m (FY, 2021)	Revenue (est.) $2.2m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income N/A	Net income ($37.2m) (FY, 2021)	Net income ($24.2m) (FY, 2025)	Net income N/A	Net income N/A
Operating ⚠
Pre-Clinical Phase Products	Pre-Clinical Phase Products N/A	Pre-Clinical Phase Products 2 (Q2, 2020)	Pre-Clinical Phase Products 4 (Q2, 2020)	Pre-Clinical Phase Products N/A	Pre-Clinical Phase Products N/A
Funding
Total funding raised	Total funding raised $ 242m	Total funding raised $ 168.5m	Total funding raised $ 225m	Total funding raised N/A	Total funding raised N/A